Bermuda
|
75-2993910
|
|
(State
or other jurisdiction of
|
(I.R.S.
Employer
|
|
incorporation
or organization)
|
Identification
No.)
|
PART
I
|
FINANCIAL
INFORMATION
|
|||
Item
1
|
-
|
Financial
Statements
|
|
|
Condensed
Consolidated Income Statement for the three months ended March 31,
2008
|
1
|
|||
Condensed
Consolidated Balance Sheet at March 31, 2008 and December 31,
2007
|
2
|
|||
Condensed
Consolidated Statement of Cash Flows for the three months ended March
31,
2008 and 2007
|
3
|
|||
Notes
to Condensed Consolidated Financial Statements
|
4
|
|||
Item
2
|
-
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
28
|
|
Item
3
|
-
|
Quantitative
and Qualitative Disclosures about Market Risk
|
44
|
|
Item
4
|
-
|
Controls
and Procedures
|
44
|
|
PART
II
|
OTHER
INFORMATION
|
|||
Item
1
|
-
|
Legal
Proceedings
|
44
|
|
Item
1A
|
-
|
Risk
Factors
|
44
|
|
Item
2
|
-
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
44
|
|
Item
6
|
-
|
Exhibits
|
45
|
|
SIGNATURES
|
46
|
|||
CERTIFICATIONS
|
Three months ended
|
|||||||
March 31,
|
|||||||
In
millions, except per share amounts
|
2008
|
2007
|
|||||
Net
revenues
|
$
|
2,163.3
|
$
|
1,976.2
|
|||
Cost
of goods sold
|
(1,540.9
|
)
|
(1,416.0
|
)
|
|||
Selling
and administrative expenses
|
(375.4
|
)
|
(351.6
|
)
|
|||
Operating
income
|
247.0
|
208.6
|
|||||
Interest
expense
|
(27.5
|
)
|
(35.6
|
)
|
|||
Other,
net
|
39.4
|
(0.1
|
)
|
||||
Earnings
before income taxes
|
258.9
|
172.9
|
|||||
Provision
for income taxes
|
(47.2
|
)
|
(16.3
|
)
|
|||
Earnings
from continuing operations
|
211.7
|
156.6
|
|||||
Discontinued
operations, net of tax
|
(30.1
|
)
|
60.9
|
||||
Net
earnings
|
$
|
181.6
|
$
|
217.5
|
|||
Basic
earnings per common share:
|
|||||||
Continuing
operations
|
$
|
0.77
|
$
|
0.51
|
|||
Discontinued
operations
|
(0.11
|
)
|
0.20
|
||||
Net
earnings
|
$
|
0.66
|
$
|
0.71
|
|||
Diluted
earnings per common share:
|
|||||||
Continuing
operations
|
$
|
0.77
|
$
|
0.50
|
|||
Discontinued
operations
|
(0.11
|
)
|
0.20
|
||||
Net
earnings
|
$
|
0.66
|
$
|
0.70
|
|||
Dividends
per common share
|
$
|
0.18
|
$
|
0.18
|
March 31,
|
December 31,
|
||||||
In
millions
|
2008
|
2007
|
|||||
ASSETS
|
|||||||
Current
assets:
|
|||||||
Cash
and cash equivalents
|
$
|
4,068.3
|
$
|
4,735.3
|
|||
Accounts
and notes receivable, less allowance of $12.4 in 2008 and $12.2 in
2007
|
1,716.6
|
1,660.7
|
|||||
Inventories
|
909.0
|
827.2
|
|||||
Other
current assets
|
463.2
|
477.5
|
|||||
Total
current assets
|
7,157.1
|
7,700.7
|
|||||
Property,
plant and equipment, net
|
935.3
|
904.9
|
|||||
Goodwill
|
4,110.9
|
3,993.3
|
|||||
Intangible
assets, net
|
740.3
|
724.6
|
|||||
Other
noncurrent assets
|
1,108.5
|
1,052.7
|
|||||
Total
assets
|
$
|
14,052.1
|
$
|
14,376.2
|
|||
LIABILITIES
AND EQUITY
|
|||||||
Current
liabilities:
|
|||||||
Accounts
payable
|
$
|
768.1
|
$
|
721.2
|
|||
Accrued
compensation and benefits
|
260.8
|
338.9
|
|||||
Accrued
expenses and other current liabilities
|
719.6
|
1,434.6
|
|||||
Short-term
borrowings and current maturities of long-term debt
|
750.0
|
741.0
|
|||||
Total
current liabilities
|
2,498.5
|
3,235.7
|
|||||
|
|||||||
Long-term
debt
|
712.7
|
712.7
|
|||||
Postemployment
and other benefit liabilities
|
937.1
|
941.9
|
|||||
Other
noncurrent liabilities
|
1,488.4
|
1,480.5
|
|||||
Minority
interests
|
96.8
|
97.5
|
|||||
Shareholders'
equity:
|
|||||||
Class
A common shares
|
272.8
|
272.6
|
|||||
Capital
in excess of par value
|
36.6
|
-
|
|||||
Retained
earnings
|
7,521.3
|
7,388.8
|
|||||
Accumulated
other comprehensive income (loss)
|
487.9
|
246.5
|
|||||
Total
shareholders' equity
|
8,318.6
|
7,907.9
|
|||||
Total
liabilities and shareholders' equity
|
$
|
14,052.1
|
$
|
14,376.2
|
Three months ended March 31,
|
|||||||
In
millions
|
2008
|
2007
|
|||||
Cash
flows from operating activities:
|
|||||||
Net
earnings
|
$
|
181.6
|
$
|
217.5
|
|||
(Income)
loss from discontinued operations, net of tax
|
30.1
|
(60.9
|
)
|
||||
Adjustments
to arrive at net cash provided by (used in) operating
activities:
|
|||||||
Depreciation
and amortization
|
38.1
|
36.0
|
|||||
Stock
settled share-based compensation
|
14.0
|
11.9
|
|||||
Changes
in other assets and liabilities, net
|
(944.0
|
)
|
(132.6
|
)
|
|||
Other,
net
|
5.5
|
7.6
|
|||||
Net
cash provided by (used in) continuing operating activities
|
(674.7
|
)
|
79.5
|
||||
Net
cash provided by (used in) discontinued operating
activities
|
(11.0
|
)
|
(33.8
|
)
|
|||
Cash
flows from investing activities:
|
|||||||
Capital
expenditures
|
(37.4
|
)
|
(29.5
|
)
|
|||
Proceeds
from sale of property, plant and equipment
|
2.1
|
1.9
|
|||||
Acquisitions,
net of cash acquired
|
(30.3
|
)
|
(3.6
|
)
|
|||
Proceeds
from business dispositions, net of cash
|
8.5
|
-
|
|||||
Other,
net
|
5.1
|
-
|
|
||||
Net
cash provided by (used in) continuing investing activities
|
(52.0
|
)
|
(31.2
|
)
|
|||
Net
cash provided by (used in) discontinued investing
activities
|
-
|
(26.1
|
)
|
||||
Cash
flows from financing activities:
|
|||||||
Increase
in short-term borrowings
|
7.2
|
104.1
|
|||||
Payments
of long-term debt
|
(0.8
|
)
|
(1.9
|
)
|
|||
Net
change in debt
|
6.4
|
102.2
|
|||||
Dividends
paid
|
(49.1
|
)
|
(55.3
|
)
|
|||
Proceeds
from exercise of stock options
|
4.2
|
44.7
|
|||||
Repurchase
of common shares by subsidiary
|
-
|
(133.6
|
)
|
||||
Other,
net
|
25.8
|
-
|
|||||
Net
cash provided by (used in) continuing financing activities
|
(12.7
|
)
|
(42.0
|
)
|
|||
Net
cash provided by (used in) discontinued financing
activities
|
-
|
-
|
|||||
Effect
of exchange rate changes on cash and cash equivalents
|
83.4
|
2.4
|
|||||
Net
increase (decrease) in cash and cash equivalents
|
(667.0
|
)
|
(51.2
|
)
|
|||
Cash
and cash equivalents - beginning of period
|
4,735.3
|
355.8
|
|||||
Cash
and cash equivalents - end of period
|
$
|
4,068.3
|
$
|
304.6
|
In
millions
|
2008
|
2007
|
|||||
Revenues
|
$
|
9.6
|
$
|
859.6
|
|||
|
|||||||
Pre-tax
earnings (loss) from operations
|
(11.2
|
)
|
81.9
|
||||
Pre-tax
gain (loss) on sale
|
(4.1
|
)
|
0.1
|
||||
Tax
expense
|
(14.8
|
)
|
(21.1
|
)
|
|||
Discontinued
operations, net
|
$
|
(30.1
|
)
|
$
|
60.9
|
In
millions
|
2008
|
2007
|
|||||
Compact
Equipment, net of tax
|
$
|
(24.4
|
)
|
$
|
60.5
|
||
Road
Development, net of tax
|
-
|
15.9
|
|||||
Other
discontinued operations, net of tax
|
(5.7
|
)
|
(15.5
|
)
|
|||
Total
discontinued operations, net of tax
|
$
|
(30.1
|
)
|
$
|
60.9
|
In
millions
|
2008
|
2007
|
|||||
Net
revenues
|
$
|
9.6
|
$
|
692.5
|
|||
|
|||||||
After-tax
earnings from operations
|
0.4
|
60.5
|
|||||
Loss
on sale, net of tax of $20.7
|
(24.8
|
)
|
-
|
||||
Total
discontinued operations, net of tax
|
$
|
(24.4
|
)
|
$
|
60.5
|
In
millions
|
2008
|
2007
|
|||||
Net
revenues
|
$
|
-
|
$
|
167.1
|
|||
|
|||||||
After-tax
earnings from operations
|
-
|
15.9
|
|||||
Total
discontinued operations, net of tax
|
$
|
-
|
$
|
15.9
|
In
millions
|
2008
|
2007
|
|||||
Retained
costs, net of tax
|
$
|
(5.7
|
)
|
$
|
(15.6
|
)
|
|
Net
gain on disposals, net of tax
|
-
|
0.1
|
|||||
Total
discontinued operations, net of tax
|
$
|
(5.7
|
)
|
$
|
(15.5
|
)
|
March
31,
|
December
31,
|
||||||
In
millions
|
2008
|
2007
|
|||||
Raw
materials
|
$
|
338.2
|
$
|
323.2
|
|||
Work-in-process
|
180.8
|
163.4
|
|||||
Finished
goods
|
476.9
|
424.9
|
|||||
995.9
|
911.5
|
||||||
LIFO
reserve
|
(86.9
|
)
|
(84.3
|
)
|
|||
Total
|
$
|
909.0
|
$
|
827.2
|
Climate
|
|||||||||||||
Control
|
Industrial
|
Security
|
|||||||||||
In
millions
|
Technologies
|
Technologies
|
Technologies
|
Total
|
|||||||||
Balance
at December 31, 2007
|
$
|
2,613.8
|
$
|
371.9
|
$
|
1,007.6
|
$
|
3,993.3
|
|||||
Acquisitions
and adjustments*
|
-
|
1.9
|
24.2
|
26.1
|
|||||||||
Translation
|
45.3
|
6.4
|
39.8
|
91.5
|
|||||||||
Balance
at March 31, 2008
|
$
|
2,659.1
|
$
|
380.2
|
$
|
1,071.6
|
$
|
4,110.9
|
*
Includes current year adjustments related to final purchase price
allocation adjustments.
|
March 31, 2008
|
December 31, 2007
|
||||||||||||
Gross
|
Accumulated
|
Gross
|
Accumulated
|
||||||||||
In
millions
|
amount
|
amortization
|
amount
|
amortization
|
|||||||||
Customer
relationships
|
$
|
510.8
|
$
|
92.1
|
$
|
502.4
|
$
|
87.4
|
|||||
Trademarks
|
122.0
|
17.7
|
114.5
|
15.6
|
|||||||||
Patents
|
39.3
|
22.4
|
38.2
|
21.2
|
|||||||||
Other
|
59.7
|
31.7
|
53.4
|
29.0
|
|||||||||
Total
amortizable intangible assets
|
731.8
|
163.9
|
708.5
|
153.2
|
|||||||||
Indefinite-lived
intangible assets
|
172.4
|
-
|
169.3
|
-
|
|||||||||
Total
|
$
|
904.2
|
$
|
163.9
|
$
|
877.8
|
$
|
153.2
|
In
millions
|
2008
|
2007
|
|||||
Service
cost
|
$
|
11.4
|
$
|
14.9
|
|||
Interest
cost
|
38.5
|
41.5
|
|||||
Expected
return on plan assets
|
(49.1
|
)
|
(58.2
|
)
|
|||
Net
amortization of:
|
|||||||
Prior
service costs
|
2.1
|
2.4
|
|||||
Transition
amount
|
0.2
|
0.2
|
|||||
Plan
net actuarial losses
|
2.4
|
4.6
|
|||||
Net
periodic pension benefit cost
|
5.5
|
5.4
|
|||||
Net
curtailment and settlement (gains) losses
|
1.3
|
-
|
|||||
Net
periodic pension benefit cost after net curtailment and settlement
(gains)
losses
|
$
|
6.8
|
$
|
5.4
|
|||
Amounts
recorded in continuing operations
|
$
|
10.5
|
$
|
8.3
|
|||
Amounts
recorded in discontinued operations
|
(3.7
|
)
|
(2.9
|
)
|
|||
Total
|
$
|
6.8
|
$
|
5.4
|
In
millions
|
2008
|
2007
|
|||||
Service
cost
|
$
|
1.0
|
$
|
3.2
|
|||
Interest
cost
|
9.5
|
14.1
|
|||||
Net
amortization of prior service gains
|
(0.9
|
)
|
(1.1
|
)
|
|||
Net
amortization of net actuarial losses
|
3.7
|
4.9
|
|||||
Net
periodic postretirement benefit cost
|
$
|
13.3
|
$
|
21.1
|
|||
Amounts
recorded in continuing operations
|
$
|
5.9
|
$
|
6.8
|
|||
Amounts
recorded in discontinued operations
|
7.4
|
14.3
|
|||||
Total
|
$
|
13.3
|
$
|
21.1
|
In
millions
|
2008
|
2007
|
|||||
Net
earnings
|
$
|
181.6
|
$
|
217.5
|
|||
Other
comprehensive income (loss):
|
|||||||
Foreign
currency translation adjustment
|
231.2
|
35.5
|
|||||
Change
in fair value of derivatives qualifying as cash flow hedges, net
of
tax
|
7.1
|
-
|
|||||
Unrealized
gain (loss) on marketable securities, net of tax
|
(1.5
|
)
|
(0.5
|
)
|
|||
Pension
and other postretirement benefits liability adjustment, net of
tax
|
4.6
|
6.9
|
|||||
Comprehensive
income
|
$
|
423.0
|
$
|
259.4
|
|
Climate
|
|
|
|
|||||||||
|
Control
|
Industrial
|
Security
|
|
|||||||||
In
millions
|
Technologies
|
Technologies
|
Technologies
|
Total
|
|||||||||
Cost
of goods sold
|
$
|
0.5
|
$
|
2.1
|
$
|
-
|
$
|
2.6
|
|||||
Selling
and administrative
|
0.5
|
0.7
|
-
|
1.2
|
|||||||||
Total
|
$
|
1.0
|
$
|
2.8
|
$
|
-
|
$
|
3.8
|
|
Climate
|
|
|
|
|||||||||
|
Control
|
Industrial
|
Security
|
|
|||||||||
In
millions
|
Technologies
|
Technologies
|
Technologies
|
Total
|
|||||||||
Balance
at December 31, 2007
|
$
|
20.8
|
$
|
0.7
|
$
|
4.0
|
$
|
25.5
|
|||||
Additions
|
1.0
|
2.8
|
-
|
3.8
|
|||||||||
Cash
and non-cash uses
|
(10.7
|
)
|
(2.2
|
)
|
(1.5
|
)
|
(14.4
|
)
|
|||||
Currency
translation
|
1.1
|
-
|
0.3
|
1.4
|
|||||||||
Balance
at March 31, 2008
|
$
|
12.2
|
$
|
1.3
|
$
|
2.8
|
$
|
16.3
|
|
2008
|
2007
|
|||||
Dividend
yield
|
1.54
|
%
|
1.75
|
%
|
|||
Volatility
|
31.50
|
%
|
26.10
|
%
|
|||
Risk-free
rate of return
|
2.75
|
%
|
4.71
|
%
|
|||
Expected
life
|
5.1
years
|
4.7
years
|
|
Shares
|
Weighted-
|
Aggregate
|
Weighted-
|
|||||||||
|
subject
|
average
|
intrinsic
|
average
|
|||||||||
|
to option
|
exercise price
|
value (millions)
|
remaining life
|
|||||||||
December
31, 2007
|
16,424,891
|
$
|
34.25
|
||||||||||
Granted
|
3,202,249
|
39.00
|
|||||||||||
Exercised
|
(126,161
|
)
|
33.41
|
||||||||||
Cancelled
|
(149,773
|
)
|
40.70
|
|
|
||||||||
Outstanding
March 31, 2008
|
19,351,206
|
$
|
34.99
|
$
|
187.5
|
6.2
|
|||||||
Exercisable
March 31, 2008
|
13,338,900
|
$
|
32.38
|
$
|
162.8
|
4.9
|
|
Shares
|
Weighted-
|
Aggregate
|
Weighted-
|
|||||||||
|
subject
|
average
|
intrinsic
|
average
|
|||||||||
|
to option
|
exercise price
|
value (millions)
|
remaining life
|
|||||||||
December
31, 2007
|
1,169,977
|
$
|
33.99
|
||||||||||
Granted
|
-
|
-
|
|||||||||||
Exercised
|
(2,874
|
)
|
30.15
|
||||||||||
Cancelled
|
(42,600
|
)
|
37.44
|
|
|
||||||||
Outstanding
March 31, 2008
|
1,124,503
|
$
|
33.87
|
$
|
12.0
|
5.2
|
|||||||
Exercisable
March 31, 2008
|
1,034,867
|
$
|
33.39
|
$
|
11.6
|
5.0
|
In
millions
|
2008
|
2007
|
|||||
Stock
options
|
$
|
13.3
|
$
|
11.4
|
|||
SARs
|
(0.3
|
)
|
0.4
|
||||
Performance
shares
|
0.8
|
4.2
|
|||||
Deferred
compensation
|
1.2
|
1.0
|
|||||
Other
|
0.3
|
0.3
|
|||||
Pre-tax
expense
|
15.3
|
17.3
|
|||||
Tax
benefit
|
(5.9
|
)
|
(6.6
|
)
|
|||
After
tax expense
|
$
|
9.4
|
$
|
10.7
|
|||
|
|||||||
Amounts
recorded in continuing operations
|
$
|
9.4
|
$
|
9.2
|
|||
Amounts
recorded in discontinued operations
|
-
|
1.5
|
|||||
Total
|
$
|
9.4
|
$
|
10.7
|
In
millions
|
2008
|
2007
|
|||||
Interest
income
|
$
|
45.6
|
$
|
2.9
|
|||
Exchange
gain (loss)
|
(1.6
|
)
|
0.1
|
||||
Minority
interests
|
(3.8
|
)
|
(3.2
|
)
|
|||
Earnings
from equity investments
|
-
|
-
|
|||||
Other
|
(0.8
|
)
|
0.1
|
||||
Other,
net
|
$
|
39.4
|
$
|
(0.1
|
)
|
In
millions
|
2008
|
2007
|
|||||
Weighted-average
number of basic shares
|
273.8
|
306.8
|
|||||
Shares
issuable under incentive stock plans
|
2.5
|
3.5
|
|||||
Weighted-average
number of diluted shares
|
276.3
|
310.3
|
|||||
Anti-dilutive
shares
|
4.3
|
4.0
|
In
millions
|
2008
|
2007
|
|||||
Net
revenues
|
|
|
|||||
Climate
Control Technologies
|
$
|
798.4
|
$
|
728.9
|
|||
Industrial
Technologies
|
743.4
|
667.7
|
|||||
Security
Technologies
|
621.5
|
579.6
|
|||||
Total
|
$
|
2,163.3
|
$
|
1,976.2
|
|||
Operating
income
|
|||||||
Climate
Control Technologies
|
$
|
80.1
|
$
|
69.4
|
|||
Industrial
Technologies
|
97.6
|
91.6
|
|||||
Security
Technologies
|
105.0
|
90.7
|
|||||
Unallocated
corporate expense
|
(35.7
|
)
|
(43.1
|
)
|
|||
Total
|
$
|
247.0
|
$
|
208.6
|
In
millions
|
2008
|
2007
|
|||||
United
States
|
$
|
830.3
|
$
|
820.5
|
|||
Non-U.S.
|
672.9
|
639.6
|
|||||
Total
|
$
|
1,503.2
|
$
|
1,460.1
|
·
|
ARPC’s
interpretation of a widely accepted forecast of the population
likely to
have been occupationally exposed to
asbestos;
|
·
|
epidemiological
studies estimating the number of people likely to develop asbestos-related
diseases such as mesothelioma and lung
cancer;
|
·
|
the
Company’s historical experience with the filing of non-malignancy claims
against it and the historical ratio between the numbers of non-malignancy
and lung cancer claims filed against the
Company;
|
·
|
ARPC’s
analysis of the number of people likely to file an asbestos-related
personal injury claim against the Company based on such epidemiological
and historical data and the Company’s most recent three-year claims
history;
|
·
|
an
analysis of the Company’s pending cases, by type of disease
claimed;
|
·
|
an
analysis of the Company’s most recent three-year history to determine the
average settlement and resolution value of claims, by type of disease
claimed;
|
·
|
an
adjustment for inflation in the future average settlement value
of claims,
at a 2.5% annual inflation rate, adjusted downward to 1.5% to take
account
of the declining value of claims resulting from the aging of the
claimant
population;
|
·
|
an
analysis of the period over which the Company has and is likely
to resolve
asbestos-related claims against it in the
future.
|
|
2002
|
2003
|
2004
|
2005
|
2006
|
2007
|
|||||||||||||
Open
claims - January 1
|
77,675
|
96,294
|
104,513
|
105,811
|
102,968
|
101,709
|
|||||||||||||
New
claims filed
|
37,172
|
30,843
|
13,541
|
11,132
|
6,457
|
5,398
|
|||||||||||||
Claims
settled
|
(16,443
|
)
|
(21,096
|
)
|
(11,503
|
)
|
(12,505
|
)
|
(6,558
|
)
|
(5,005
|
)
|
|||||||
Claims
dismissed
|
(2,110
|
)
|
(1,528
|
)
|
(740
|
)
|
(1,470
|
)
|
(1,158
|
)
|
(1,479
|
)
|
|||||||
Open
claims - December 31
|
96,294
|
104,513
|
105,811
|
102,968
|
101,709
|
100,623
|
In
millions
|
2008
|
2007
|
|||||
Balance
at beginning of period
|
$
|
146.9
|
$
|
137.1
|
|||
Reductions
for payments
|
(17.9
|
)
|
(20.2
|
)
|
|||
Accruals
for warranties issued during the current period
|
16.3
|
24.0
|
|||||
Changes
to accruals related to preexisting warranties
|
(0.6
|
)
|
(0.3
|
)
|
|||
Acquisitions
|
-
|
0.1
|
|||||
Translation
|
3.5
|
1.0
|
|||||
Balance
at end of period
|
$
|
148.2
|
$
|
141.7
|
·
|
Level
1 – Inputs based on quoted prices in active markets for identical assets
or liabilities.
|
·
|
Level
2 – Inputs other than Level 1 quoted prices, such as quoted prices
for
similar assets or liabilities; quoted prices in markets that are
not
active; or other inputs that are observable or can be corroborated
by
observable market data for substantially the full term of the asset
or
liability.
|
· |
Level
3 – Unobservable inputs based on little or no market activity and that
are
significant to the fair value of the assets and liabilities.
|
|
Fair
value measurements
|
Total
|
|||||||||||
In
millions
|
Level
1
|
Level
2
|
Level
3
|
fair
value
|
|||||||||
Assets:
|
|
|
|
|
|||||||||
Cash
and cash equivalents
|
$
|
4,068.3
|
$
|
-
|
$
|
-
|
$
|
4,068.3
|
|||||
Marketable
securities
|
11.3
|
-
|
-
|
11.3
|
|||||||||
Derivative
instruments
|
-
|
7.5
|
-
|
7.5
|
|||||||||
Benefit
trust assets
|
-
|
139.3
|
-
|
139.3
|
|||||||||
Total
|
$
|
4,079.6
|
$
|
146.8
|
$
|
-
|
$
|
4,226.4
|
|||||
|
|||||||||||||
Liabilities:
|
|||||||||||||
Derivative
instruments
|
$
|
-
|
$
|
1.8
|
$
|
-
|
$
|
1.8
|
|||||
Benefit
liabilities
|
-
|
104.3
|
-
|
104.3
|
|||||||||
Total
|
$
|
-
|
$
|
106.1
|
$
|
-
|
$
|
106.1
|
·
|
Cash
and cash equivalents –
These amounts include cash on hand, demand deposits and all highly
liquid
investments with original maturities at the time of purchase of
three
months or less and are held in U.S and non-U.S.
currencies.
|
·
|
Marketable
securities –
These securities include investments in publically traded stock
of
non-U.S. companies held by non-U.S. subsidiaries of the Company.
The fair
value is obtained for the securities based on observable market
prices
quoted on public stock exchanges.
|
·
|
Derivatives
instruments –
These instruments include forward contracts related to non-U.S.
currencies
and commodities. The fair value of the derivative instruments are
determined based on a pricing model that uses inputs from actively
quoted
currency and commodity markets that are readily accessible and
observable.
|
·
|
Benefit
trust assets –
These assets include money market funds and insurance contracts
that are
the underlying for the benefit assets. The fair value of the assets
is
based on observable market prices quoted in a readily accessible
and
observable market.
|
·
|
Benefit
liabilities –
These liabilities include benefits given to certain executives
of the
Company, including deferred compensation and executive death benefits.
The
fair value is based on the underlying investment portfolio of the
deferred
compensation and the specific benefits guaranteed in a death benefit
contract with each executive.
|
IR
|
IR
|
Other
|
Consolidating
|
IR
Limited
|
||||||||||||
In
millions
|
Limited
|
New
Jersey
|
Subsidiaries
|
Adjustments
|
Consolidated
|
|||||||||||
Net
revenues
|
$
|
-
|
$
|
227.8
|
$
|
1,935.5
|
$
|
-
|
$
|
2,163.3
|
||||||
Cost
of goods sold
|
-
|
(169.4
|
)
|
(1,371.5
|
)
|
-
|
(1,540.9
|
)
|
||||||||
Selling
and administrative expenses
|
(14.5
|
)
|
(75.4
|
)
|
(285.5
|
)
|
-
|
(375.4
|
)
|
|||||||
Operating
income
|
(14.5
|
)
|
(17.0
|
)
|
278.5
|
-
|
247.0
|
|||||||||
Equity
earnings in affiliates (net of tax)
|
222.0
|
54.1
|
(9.2
|
)
|
(266.9
|
)
|
-
|
|||||||||
Interest
expense
|
(3.9
|
)
|
(16.7
|
)
|
(6.9
|
)
|
-
|
(27.5
|
)
|
|||||||
Intercompany
interest and fees
|
(22.0
|
)
|
(61.1
|
)
|
83.1
|
-
|
-
|
|||||||||
Other,
net
|
-
|
6.5
|
32.9
|
-
|
39.4
|
|||||||||||
Earnings
(loss) before income taxes
|
181.6
|
(34.2
|
)
|
378.4
|
(266.9
|
)
|
258.9
|
|||||||||
(Benefit)
provision for income taxes
|
-
|
20.4
|
(67.6
|
)
|
-
|
(47.2
|
)
|
|||||||||
Earnings
(loss) from continuing operations
|
181.6
|
(13.8
|
)
|
310.8
|
(266.9
|
)
|
211.7
|
|||||||||
Discontinued
operations, net of tax
|
-
|
4.6
|
(34.7
|
)
|
-
|
(30.1
|
)
|
|||||||||
Net
earnings (loss)
|
$
|
181.6
|
$
|
(9.2
|
)
|
$
|
276.1
|
$
|
(266.9
|
)
|
$
|
181.6
|
|
IR
|
|
IR
|
Other
|
Consolidating
|
IR
Limited
|
||||||||||
In
millions
|
Limited
|
New
Jersey
|
Subsidiaries
|
Adjustments
|
Consolidated
|
|||||||||||
Net
revenues
|
$
|
-
|
$
|
222.9
|
$
|
1,753.3
|
$
|
-
|
$
|
1,976.2
|
||||||
Cost
of goods sold
|
-
|
(157.9
|
)
|
(1,258.1
|
)
|
-
|
(1,416.0
|
)
|
||||||||
Selling
and administrative expenses
|
(11.5
|
)
|
(83.9
|
)
|
(256.2
|
)
|
-
|
(351.6
|
)
|
|||||||
Operating
income
|
(11.5
|
)
|
(18.9
|
)
|
239.0
|
-
|
208.6
|
|||||||||
Equity
earnings in affiliates (net of tax)
|
249.9
|
115.5
|
3.1
|
(368.5
|
)
|
-
|
||||||||||
Interest
expense
|
(11.0
|
)
|
(17.2
|
)
|
(7.4
|
)
|
-
|
(35.6
|
)
|
|||||||
Intercompany
interest and fees
|
(10.2
|
)
|
(118.6
|
)
|
128.8
|
-
|
-
|
|||||||||
Other,
net
|
0.3
|
(0.4
|
)
|
-
|
-
|
(0.1
|
)
|
|||||||||
Earnings
(loss) before income taxes
|
217.5
|
(39.6
|
)
|
363.5
|
(368.5
|
)
|
172.9
|
|||||||||
(Benefit)
provision for income taxes
|
-
|
46.3
|
(62.6
|
)
|
-
|
(16.3
|
)
|
|||||||||
Earnings
(loss) from continuing operations
|
217.5
|
6.7
|
300.9
|
(368.5
|
)
|
156.6
|
||||||||||
Discontinued
operations, net of tax
|
-
|
(3.6
|
)
|
64.5
|
-
|
60.9
|
||||||||||
Net
earnings (loss)
|
$
|
217.5
|
$
|
3.1
|
$
|
365.4
|
$
|
(368.5
|
)
|
$
|
217.5
|
IR
|
IR
|
Other
|
Consolidating
|
IR
Limited
|
||||||||||||
In
millions
|
Limited
|
New
Jersey
|
Subsidiaries
|
Adjustments
|
Consolidated
|
|||||||||||
Current
assets:
|
|
|||||||||||||||
Cash
and cash equivalents
|
$
|
5.1
|
$
|
190.4
|
$
|
3,872.8
|
$
|
-
|
$
|
4,068.3
|
||||||
Accounts
and notes receivable, net
|
0.1
|
276.0
|
1,440.5
|
-
|
1,716.6
|
|||||||||||
Inventories
|
-
|
74.5
|
834.5
|
-
|
909.0
|
|||||||||||
Other
current assets
|
-
|
120.7
|
342.5
|
-
|
463.2
|
|||||||||||
Accounts
and notes receivable affiliates
|
15.7
|
6,196.3
|
26,475.9
|
(32,687.9
|
)
|
-
|
||||||||||
Total
current assets
|
20.9
|
6,857.9
|
32,966.2
|
(32,687.9
|
)
|
7,157.1
|
||||||||||
Investment
in affiliates
|
10,580.4
|
9,282.2
|
40,420.9
|
(60,283.5
|
)
|
-
|
||||||||||
Property,
plant and equipment, net
|
-
|
159.4
|
775.9
|
-
|
935.3
|
|||||||||||
Intangible
assets, net
|
-
|
79.9
|
4,771.3
|
-
|
4,851.2
|
|||||||||||
Other
noncurrent assets
|
1.3
|
711.3
|
395.9
|
-
|
1,108.5
|
|||||||||||
Total
assets
|
$
|
10,602.6
|
$
|
17,090.7
|
$
|
79,330.2
|
$
|
(92,971.4
|
)
|
$
|
14,052.1
|
|||||
Current
liabilities:
|
||||||||||||||||
Accounts
payable and accruals
|
$
|
10.8
|
$
|
485.3
|
$
|
1,252.4
|
$
|
-
|
$
|
1,748.5
|
||||||
Short
term borrowings and current maturities of long-term debt
|
-
|
554.9
|
195.1
|
-
|
750.0
|
|||||||||||
Accounts
and note payable affiliates
|
238.1
|
6,941.2
|
25,508.6
|
(32,687.9
|
)
|
-
|
||||||||||
Total
current liabilities
|
248.9
|
7,981.4
|
26,956.1
|
(32,687.9
|
)
|
2,498.5
|
||||||||||
Long-term
debt
|
299.1
|
403.2
|
10.4
|
-
|
712.7
|
|||||||||||
Note
payable affiliate
|
1,550.0
|
2,097.4
|
-
|
(3,647.4
|
)
|
-
|
||||||||||
Other
noncurrent liabilities
|
186.0
|
1,925.4
|
410.9
|
-
|
2,522.3
|
|||||||||||
Total
liabilities
|
2,284.0
|
12,407.4
|
27,377.4
|
(36,335.3
|
)
|
5,733.5
|
||||||||||
Shareholders'
equity:
|
||||||||||||||||
Class
A common shares
|
370.3
|
-
|
(97.4
|
)
|
(0.1
|
)
|
272.8
|
|||||||||
Class
B common shares
|
270.6
|
-
|
-
|
(270.6
|
)
|
-
|
||||||||||
Common
shares
|
-
|
-
|
2,362.8
|
(2,362.8
|
)
|
-
|
||||||||||
Other
shareholders' equity
|
11,149.4
|
5,389.6
|
52,687.1
|
(61,668.2
|
)
|
7,557.9
|
||||||||||
Accumulated
other comprehensive income (loss)
|
809.6
|
(295.2
|
)
|
719.9
|
(746.4
|
)
|
487.9
|
|||||||||
12,599.9
|
5,094.4
|
55,672.4
|
(65,048.1
|
)
|
8,318.6
|
|||||||||||
Less:
Contra account
|
(4,281.3
|
)
|
(411.1
|
)
|
(3,719.6
|
)
|
8,412.0
|
-
|
||||||||
Total
shareholders' equity
|
8,318.6
|
4,683.3
|
51,952.8
|
(56,636.1
|
)
|
8,318.6
|
||||||||||
Total
liabilities and equity
|
$
|
10,602.6
|
$
|
17,090.7
|
$
|
79,330.2
|
$
|
(92,971.4
|
)
|
$
|
14,052.1
|
In
millions
|
IR
Limited |
IR
New Jersey |
Other
Subsidiaries |
Consolidating
Adjustments |
IR Limited
Consolidated
|
|||||||||||
Current
assets:
|
||||||||||||||||
Cash
and cash equivalents
|
$
|
0.6
|
$
|
545.5
|
$
|
4,189.2
|
$
|
-
|
$
|
4,735.3
|
||||||
Accounts
and notes receivable, net
|
0.4
|
266.4
|
1,393.9
|
-
|
1,660.7
|
|||||||||||
Inventories
|
-
|
78.7
|
748.5
|
-
|
827.2
|
|||||||||||
Other
current assets
|
-
|
137.2
|
340.3
|
-
|
477.5
|
|||||||||||
Accounts
and notes receivable affiliates
|
13.5
|
7,630.2
|
25,528.6
|
(33,172.3
|
)
|
-
|
||||||||||
Total
current assets
|
14.5
|
8,658.0
|
32,200.5
|
(33,172.3
|
)
|
7,700.7
|
||||||||||
Investment
in affiliates
|
10,033.7
|
9,221.1
|
40,217.2
|
(59,472.0
|
)
|
-
|
||||||||||
Property,
plant and equipment, net
|
-
|
152.9
|
752.0
|
-
|
904.9
|
|||||||||||
Intangible
assets, net
|
-
|
79.9
|
4,638.0
|
-
|
4,717.9
|
|||||||||||
Other
noncurrent assets
|
1.5
|
704.6
|
346.6
|
-
|
1,052.7
|
|||||||||||
Total
assets
|
$
|
10,049.7
|
$
|
18,816.5
|
$
|
78,154.3
|
$
|
(92,644.3
|
)
|
$
|
14,376.2
|
|||||
Current
liabilities:
|
||||||||||||||||
Accounts
payable and accruals
|
$
|
6.9
|
$
|
529.7
|
$
|
1,958.1
|
$
|
-
|
$
|
2,494.7
|
||||||
Short
term borrowings and current maturities of long-term debt
|
-
|
555.4
|
185.6
|
-
|
741.0
|
|||||||||||
Accounts
and note payable affiliates
|
89.1
|
7,010.2
|
26,073.0
|
(33,172.3
|
)
|
-
|
||||||||||
Total
current liabilities
|
96.0
|
8,095.3
|
28,216.7
|
(33,172.3
|
)
|
3,235.7
|
||||||||||
Long-term
debt
|
299.1
|
403.2
|
10.4
|
-
|
712.7
|
|||||||||||
Note
payable affiliate
|
1,550.0
|
2,097.4
|
-
|
(3,647.4
|
)
|
-
|
||||||||||
Other
noncurrent liabilities
|
196.7
|
1,917.0
|
406.2
|
-
|
2,519.9
|
|||||||||||
Total
liabilities
|
2,141.8
|
12,512.9
|
28,633.3
|
(36,819.7
|
)
|
6,468.3
|
||||||||||
Shareholders'
equity:
|
||||||||||||||||
Class
A common shares
|
370.0
|
-
|
(97.4
|
)
|
-
|
272.6
|
||||||||||
Class
B common shares
|
270.6
|
-
|
-
|
(270.6
|
)
|
-
|
||||||||||
Common
shares
|
-
|
-
|
2,362.8
|
(2,362.8
|
)
|
-
|
||||||||||
Other
shareholders' equity
|
11,046.3
|
7,039.7
|
50,533.8
|
(61,231.0
|
)
|
7,388.8
|
||||||||||
Accumulated
other comprehensive income (loss)
|
568.5
|
|
(320.9
|
) |
503.5
|
|
(504.6
|
)
|
246.5 | |||||||
12,255.4
|
6,718.8
|
53,302.7
|
(64,369.0
|
)
|
7,907.9
|
|||||||||||
Less:
Contra account
|
(4,347.5
|
)
|
(415.2
|
)
|
(3,781.7
|
)
|
8,544.4
|
-
|
||||||||
Total
shareholders' equity
|
7,907.9
|
6,303.6
|
49,521.0
|
(55,824.6
|
)
|
7,907.9
|
||||||||||
Total
liabilities and equity
|
$
|
10,049.7
|
$
|
18,816.5
|
$
|
78,154.3
|
$
|
(92,644.3
|
)
|
$
|
14,376.2
|
In
millions
|
IR
Limited |
IR
New Jersey |
Other
Subsidiaries |
IR
Limited
Consolidated |
|||||||||
Net
cash provided by (used in) continuing operating activities
|
$
|
(20.8
|
)
|
$
|
(298.5
|
)
|
$
|
(355.4
|
)
|
$
|
(674.7
|
)
|
|
Net
cash provided by (used in) discontinued operating
activities
|
-
|
4.5
|
(15.5
|
)
|
(11.0
|
)
|
|||||||
Cash
flows from investing activities:
|
|||||||||||||
Capital
expenditures
|
-
|
(14.6
|
)
|
(22.8
|
)
|
(37.4
|
)
|
||||||
Proceeds
from sale of property, plant and equipment
|
-
|
-
|
2.1
|
2.1
|
|||||||||
Acquisitions,
net of cash
|
-
|
-
|
(30.3
|
)
|
(30.3
|
)
|
|||||||
Proceeds
from business disposition, net of cash
|
-
|
-
|
8.5
|
8.5
|
|||||||||
Other,
net
|
-
|
5.4
|
(0.3
|
)
|
5.1
|
||||||||
Net
cash provided by (used in) continuing investing activities
|
-
|
(9.2
|
)
|
(42.8
|
)
|
(52.0
|
)
|
||||||
Net
cash provided by (used in) discontinued investing
activities
|
-
|
-
|
-
|
-
|
|||||||||
Cash
flows from financing activities:
|
|||||||||||||
Net
change in debt
|
-
|
(0.5
|
)
|
6.9
|
6.4
|
||||||||
Net
inter-company proceeds (payments)
|
136.4
|
(81.3
|
)
|
(55.1
|
)
|
-
|
|||||||
Dividends
(paid) received
|
(115.3
|
)
|
4.1
|
62.1
|
(49.1
|
)
|
|||||||
Proceeds
from the exercise of stock options
|
4.2
|
-
|
-
|
4.2
|
|||||||||
Repurchase
of common shares by subsidiary
|
-
|
-
|
-
|
-
|
|||||||||
Other,
net
|
-
|
25.8
|
-
|
25.8
|
|||||||||
Net
cash provided by (used in) continuing financing activities
|
25.3
|
(51.9
|
)
|
13.9
|
(12.7
|
)
|
|||||||
Net
cash provided by (used in) discontinued financing
activities
|
-
|
-
|
-
|
-
|
|||||||||
Effect
of exchange rate changes on cash and cash equivalents
|
-
|
-
|
83.4
|
83.4
|
|||||||||
Net
increase (decrease) in cash and cash equivalents
|
4.5
|
(355.1
|
)
|
(316.4
|
)
|
(667.0
|
)
|
||||||
Cash
and cash equivalents - beginning of period
|
0.6
|
545.5
|
4,189.2
|
4,735.3
|
|||||||||
Cash
and cash equivalents - end of period
|
$
|
5.1
|
$
|
190.4
|
$
|
3,872.8
|
$
|
4,068.3
|
In
millions
|
IR
Limited |
IR
New Jersey |
Other
Subsidiaries |
IR
Limited
Consolidated |
|||||||||
Net
cash provided by (used in) continuing operating activities
|
$
|
(15.2
|
)
|
$
|
(64.6
|
)
|
$
|
159.3
|
$
|
79.5
|
|||
Net
cash provided by (used in) discontinued operating
activities
|
-
|
(24.1
|
)
|
(9.7
|
)
|
(33.8
|
)
|
||||||
Cash
flows from investing activities:
|
|||||||||||||
Capital
expenditures
|
-
|
(9.1
|
)
|
(20.4
|
)
|
(29.5
|
)
|
||||||
Proceeds
from sale of property, plant and equipment
|
-
|
-
|
1.9
|
1.9
|
|||||||||
Acquisitions,
net of cash
|
-
|
(0.6
|
)
|
(3.0
|
)
|
(3.6
|
)
|
||||||
Proceeds
from business disposition, net of cash
|
-
|
-
|
-
|
-
|
|||||||||
Other,
net
|
-
|
-
|
-
|
|
-
|
|
|||||||
Net
cash provided by (used in) continuing investing activities
|
-
|
(9.7
|
)
|
(21.5
|
)
|
(31.2
|
)
|
||||||
Net
cash provided by (used in) discontinued investing
activities
|
-
|
(3.6
|
)
|
(22.5
|
)
|
(26.1
|
)
|
||||||
Cash
flows from financing activities:
|
|||||||||||||
Net
change in debt
|
108.5
|
(1.0
|
)
|
(5.3
|
)
|
102.2
|
|||||||
Net
inter-company proceeds (payments)
|
(25.3
|
)
|
51.4
|
(26.1
|
)
|
-
|
|||||||
Dividends
(paid) received
|
(114.4
|
)
|
4.1
|
55.0
|
(55.3
|
)
|
|||||||
Proceeds
from the exercise of stock options
|
44.7
|
-
|
-
|
44.7
|
|||||||||
Repurchase
of common shares by subsidiary
|
-
|
-
|
(133.6
|
)
|
(133.6
|
)
|
|||||||
Net
cash provided by (used in) continuing financing activities
|
13.5
|
54.5
|
(110.0
|
)
|
(42.0
|
)
|
|||||||
Net
cash provided by (used in) discontinued financing
activities
|
-
|
-
|
-
|
-
|
|||||||||
Effect
of exchange rate changes on cash and cash equivalents
|
-
|
-
|
2.4
|
2.4
|
|||||||||
Net
increase (decrease) in cash and cash equivalents
|
(1.7
|
)
|
(47.5
|
)
|
(2.0
|
)
|
(51.2
|
)
|
|||||
Cash
and cash equivalents - beginning of period
|
1.7
|
81.6
|
272.5
|
355.8
|
|||||||||
Cash
and cash equivalents - end of period
|
$
|
-
|
$
|
34.1
|
$
|
270.5
|
$
|
304.6
|
·
|
Dramatic
Growth, by developing innovative products and solutions that improve
our
customers’ operations, expanding highly profitable recurring revenues and
executing strategic acquisitions;
|
·
|
Operational
Excellence, by fostering a lean culture of continuous improvement
and cost
control; and
|
·
|
Dual
Citizenship, by encouraging our employees’ active collaboration with
colleagues across business units and geographic regions to achieve
superior business results.
|
For the three months ended March 31,
|
|||||||||||||
In
millions, except per share amounts
|
2008
|
% of
revenues |
2007
|
% of
revenues |
|||||||||
Net
revenues
|
$
|
2,163.3
|
$
|
1,976.2
|
|||||||||
Cost
of goods sold
|
(1,540.9
|
)
|
71.2
|
%
|
(1,416.0
|
)
|
71.6
|
%
|
|||||
Selling
and administrative expenses
|
(375.4
|
)
|
17.4
|
%
|
(351.6
|
)
|
17.8
|
%
|
|||||
Operating
income
|
247.0
|
11.4
|
%
|
208.6
|
10.6
|
%
|
|||||||
Interest
expense
|
(27.5
|
)
|
(35.6
|
)
|
|||||||||
Other,
net
|
39.4
|
(0.1
|
)
|
||||||||||
Earnings
before income taxes
|
258.9
|
172.9
|
|||||||||||
Provision
for income taxes
|
(47.2
|
)
|
(16.3
|
)
|
|||||||||
Earnings
from continuing operations
|
211.7
|
156.6
|
|||||||||||
Discontinued
operations, net of tax
|
(30.1
|
)
|
60.9
|
||||||||||
Net
earnings
|
$
|
181.6
|
$
|
217.5
|
|||||||||
Diluted
earnings per common share:
|
|||||||||||||
Continuing
operations
|
$
|
0.77
|
$
|
0.50
|
|||||||||
Discontinued
operations
|
(0.11
|
)
|
0.20
|
||||||||||
Net
earnings
|
$
|
0.66
|
$
|
0.70
|
Volume/product
mix
|
1.5
|
%
|
||
Pricing
|
2.5
|
%
|
||
Currency
exchange rates
|
4.5
|
%
|
||
Acquisitions
|
1.0
|
%
|
||
Total
|
9.5
|
%
|
In
millions
|
2008
|
2007
|
|||||
Interest
income
|
$
|
45.6
|
$
|
2.9
|
|||
Exchange
gain (loss)
|
(1.6
|
)
|
0.1
|
||||
Minority
interests
|
(3.8
|
)
|
(3.2
|
)
|
|||
Earnings
from equity investments
|
-
|
-
|
|||||
Other
|
(0.8
|
)
|
0.1
|
||||
Other,
net
|
$
|
39.4
|
$
|
(0.1
|
)
|
Three months ended March 31,
|
||||||||||
In
millions
|
2008
|
2007
|
% change
|
|||||||
Net
revenues
|
$
|
798.4
|
$
|
728.9
|
9.5
|
%
|
||||
Operating
income
|
80.1
|
69.4
|
15.4
|
%
|
||||||
Operating
margin
|
10.0
|
%
|
9.5
|
%
|
Three months ended March 31,
|
||||||||||
In
millions
|
2008
|
2007
|
% change
|
|||||||
Net
revenues
|
$
|
743.4
|
$
|
667.7
|
11.3
|
%
|
||||
Operating
income
|
97.6
|
91.6
|
6.6
|
%
|
||||||
Operating
margin
|
13.1
|
%
|
13.7
|
%
|
|
Three months ended March 31,
|
||||||||||
In
millions
|
2008
|
2007
|
% change
|
|||||||
Net
revenues
|
$
|
621.5
|
$
|
579.6
|
7.2
|
%
|
||||
Operating
income
|
105.0
|
90.7
|
15.8
|
%
|
||||||
Operating
margin
|
16.9
|
%
|
15.6
|
%
|
|
In
millions
|
2008
|
2007
|
|||||
Revenues
|
$
|
9.6
|
$
|
859.6
|
|||
|
|
|
|||||
Pre-tax
earnings (loss) from operations
|
(11.2
|
)
|
81.9
|
||||
Pre-tax
gain (loss) on sale
|
(4.1
|
)
|
0.1
|
||||
Tax
expense
|
(14.8
|
)
|
(21.1
|
)
|
|||
Discontinued
operations, net
|
$
|
(30.1
|
)
|
$
|
60.9
|
In
millions
|
2008
|
2007
|
|||||
Compact
Equipment, net of tax
|
$
|
(24.4
|
)
|
$
|
60.5
|
||
Road
Development, net of tax
|
-
|
15.9
|
|||||
Other
discontinued operations, net of tax
|
(5.7
|
)
|
(15.5
|
)
|
|||
Total
discontinued operations, net of tax
|
$
|
(30.1
|
)
|
$
|
60.9
|
In
millions
|
2008
|
2007
|
|||||
Net
revenues
|
$
|
9.6
|
$
|
692.5
|
|||
|
|
|
|||||
After-tax
earnings from operations
|
0.4
|
60.5
|
|||||
Loss
on sale, net of tax of $20.7
|
(24.8
|
)
|
-
|
||||
Total
discontinued operations, net of tax
|
$
|
(24.4
|
)
|
$
|
60.5
|
In
millions
|
2008
|
2007
|
|||||
Net
revenues
|
$
|
-
|
$
|
167.1
|
|||
|
|
|
|||||
After-tax
earnings from operations
|
-
|
15.9
|
|||||
Total
discontinued operations, net of tax
|
$
|
-
|
$
|
15.9
|
In
millions
|
2008
|
2007
|
|||||
Retained
costs, net of tax
|
$
|
(5.7
|
)
|
$
|
(15.6
|
)
|
|
Net
gain on disposals, net of tax
|
-
|
0.1
|
|||||
Total
discontinued operations, net of tax
|
$
|
(5.7
|
)
|
$
|
(15.5
|
)
|
In
millions
|
2008
|
2007
|
|||||
Operating
cash flow provided by (used in) continuing operations
|
$
|
(674.7
|
)
|
$
|
79.5
|
||
Investing
cash flow provided by (used in) continuing operations
|
(52.0
|
)
|
(31.2
|
)
|
|||
Financing
cash flow provided by (used in) continuing operations
|
(12.7
|
)
|
(42.0
|
)
|
|
March 31,
|
December 31,
|
|||||
In
millions
|
2008
|
2007
|
|||||
Cash
and cash equivalents
|
$
|
4,068.3
|
$
|
4,735.3
|
|||
Total
debt
|
1,462.7
|
1,453.7
|
|||||
Total
shareholders' equity
|
8,318.6
|
7,907.9
|
|||||
Debt-to-total
capital ratio
|
14.8
|
%
|
15.4
|
%
|
·
|
ARPC’s
interpretation of a widely accepted forecast of the population likely
to
have been occupationally exposed to
asbestos;
|
·
|
epidemiological
studies estimating the number of people likely to develop asbestos-related
diseases such as mesothelioma and lung
cancer;
|
·
|
the
Company’s historical experience with the filing of non-malignancy claims
against it and the historical ratio between the numbers of non-malignancy
and lung cancer claims filed against the
Company;
|
·
|
ARPC’s
analysis of the number of people likely to file an asbestos-related
personal injury claim against the Company based on such epidemiological
and historical data and the Company’s most recent three-year claims
history;
|
·
|
an
analysis of the Company’s pending cases, by type of disease
claimed;
|
·
|
an
analysis of the Company’s most recent three-year history to determine the
average settlement and resolution value of claims, by type of disease
claimed;
|
·
|
an
adjustment for inflation in the future average settlement value of
claims,
at a 2.5% annual inflation rate, adjusted downward to 1.5% to take
account
of the declining value of claims resulting from the aging of the
claimant
population;
|
·
|
an
analysis of the period over which the Company has and is likely to
resolve
asbestos-related claims against it in the
future.
|
|
2002
|
2003
|
2004
|
2005
|
2006
|
2007
|
|||||||||||||
Open
claims - January 1
|
77,675
|
96,294
|
104,513
|
105,811
|
102,968
|
101,709
|
|||||||||||||
New
claims filed
|
37,172
|
30,843
|
13,541
|
11,132
|
6,457
|
5,398
|
|||||||||||||
Claims
settled
|
(16,443
|
)
|
(21,096
|
)
|
(11,503
|
)
|
(12,505
|
)
|
(6,558
|
)
|
(5,005
|
)
|
|||||||
Claims
dismissed
|
(2,110
|
)
|
(1,528
|
)
|
(740
|
)
|
(1,470
|
)
|
(1,158
|
)
|
(1,479
|
)
|
|||||||
Open
claims - December 31
|
96,294
|
104,513
|
105,811
|
102,968
|
101,709
|
100,623
|
In
millions
|
2008
|
2007
|
|||||
Balance
at beginning of period
|
$
|
146.9
|
$
|
137.1
|
|||
Reductions
for payments
|
(17.9
|
)
|
(20.2
|
)
|
|||
Accruals
for warranties issued during the current period
|
16.3
|
24.0
|
|||||
Changes
to accruals related to preexisting warranties
|
(0.6
|
)
|
(0.3
|
)
|
|||
Acquisitions
|
-
|
0.1
|
|||||
Translation
|
3.5
|
1.0
|
|||||
Balance
at end of period
|
$
|
148.2
|
$
|
141.7
|
Exhibit No.
|
Description
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a),
as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Filed herewith.
|
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Rule 13a-14(a) or Rule 15d-14(a),
as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Filed herewith.
|
|
32
|
Certifications
of Chief Executive Officer and Chief Financial Officer Pursuant to
Rule
13a-14(b) or Rule 15d-14(b) and 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. Filed
herewith.
|
Date:
May 12, 2008
|
/s/
James V. Gelly
|
James
V. Gelly, Senior Vice President
|
|
and
Chief Financial Officer
|
|
Principal
Financial Officer
|
|
Date:
May 12, 2008
|
/s/
Richard W. Randall
|
Richard
W. Randall, Vice President and
|
|
Controller
|
|
Principal
Accounting Officer
|